Healthcare / Health Information ServicesIstanbul
$5.65
+0.22 (+4.05%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 22%
FCF escenarios
weak_data · normalized FCF $45.4M · quality 48.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
68/100
B
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.3B
P/E
28.3x
↑EV/EBITDA
16.7x
↑ROE
13.2%
↑Gross Margin
39.5%
↓Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+53.4%
FCF CAGR
+57.3%
FCF margin
12.3%
FCF / Net income
0.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $855.1M · net income $222.9M · FCF $105.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $855.1M | $855.1M | $629.0M | $360.7M | $237.1M |
| Net Income | $222.9M | $222.9M | $196.7M | $214.7M | $24.0M |
| EBITDA | $420.7M | $420.7M | $297.9M | $116.5M | $90.5M |
| EPS | 0.18 | 0.18 | 0.21 | 0.23 | 0.03 |
| Gross Margin | 39.5% | 39.5% | 27.6% | 25.9% | 37.3% |
| Operating Margin | 33.5% | 33.5% | 20.8% | 13.8% | 29.1% |
| Net Margin | 26.1% | 26.1% | 31.3% | 59.5% | 10.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.04 | 0.04 | 0.03 | 0.03 | 0.01 |
| Current Ratio | 2.31 | 2.31 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $105.0M | $105.0M | $45.4M | $-35.5M | $27.0M |
| Returns | |||||
| ROE | 13.2% | 13.2% | 13.4% | 22.1% | 4.5% |
| Valuation | |||||
| P/E | 28.25 | 28.25 | 12.26 | 4.58 | 27.10 |
| EV/EBITDA | 16.72 | 16.72 | 8.11 | 8.60 | 6.83 |
| P/B | 4.19 | 4.19 | 1.64 | 1.01 | 1.22 |
| Growth & Yield | |||||
| Revenue Growth | 35.9% | 35.9% | 74.4% | 52.1% | — |
| EPS Growth | -15.3% | -15.3% | -8.1% | 794.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
41.1%
EPS terminal req.
$0.50
Spread vs growth
-56.4%
5Y implied EPS CAGR
27.7%
EPS terminal req.
$0.61
Spread vs growth
-43.1%
10Y implied EPS CAGR
18.5%
EPS terminal req.
$0.98
Spread vs growth
-33.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+178.2%
Start / end P/E
9.6x → 31.7x
EPS bridge
0.21 → 0.18
Residual
-35.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.